IONQ.NYSEIonq, INC

Form 4: IonQ Director Raymond W Granted 3,063 RSUs

Sentiment:

Insider Transaction Report


IonQ Director Raymond John W received a grant of 3,063 restricted stock units, which are set to vest by mid-2026 contingent on his continued service.

Summary

  • Raymond John W, a Director of IonQ, Inc. (IONQ), was granted 3,063 shares of Common Stock in the form of Restricted Stock Units (RSUs).
  • The transaction occurred on September 25, 2025.
  • These RSUs will vest in full on the earlier of the 2026 Annual Meeting date (or the day prior if service ends) or June 18, 2026.
  • Vesting is contingent upon Mr. Raymond's continued service as a member of the Board of Directors through the vesting date.
  • The acquisition price for these RSUs was $0, which is typical for such grants.
  • Following this transaction, Mr. Raymond beneficially owns 3,063 shares directly.

Sentiment

Score: 6

Explanation: The grant of Restricted Stock Units to a director is a routine event that aligns the director's interests with shareholders, indicating continued commitment. It is not a significant market-moving event but reflects standard corporate governance practices.

Positives

  • Aligns the director's interests with those of shareholders through equity compensation.
  • Incentivizes continued service and performance from a key board member.

Negatives

  • Potential for minor dilution from the issuance of new shares upon vesting, though the amount is small.

Risks

  • The RSUs are subject to forfeiture if the reporting person's service as a director ceases before the specified vesting date.

Future Outlook

The 3,063 Restricted Stock Units are scheduled to vest in full on the earlier of the 2026 Annual Meeting date (or the date immediately prior if service ends at the meeting) or June 18, 2026, provided the director maintains continuous service on the Board.

Industry Context

This RSU grant is a standard practice in corporate governance for publicly traded companies, aiming to align the interests of directors with those of shareholders by providing equity-based compensation. It is common in the technology sector, including quantum computing, to attract and retain experienced board members.

Comparison to Industry Standards

  • The grant of Restricted Stock Units (RSUs) to a director is a common form of non-cash compensation across various industries, including high-growth technology sectors like quantum computing.
  • The vesting schedule, tied to continued service and a future annual meeting or specific date, is typical for director equity awards, similar to practices observed at companies like Google (Alphabet) or Microsoft that use RSUs to incentivize long-term commitment.
  • The $0 acquisition price is standard for RSU grants, as they represent a right to receive shares upon vesting, not a purchase.

Stakeholder Impact

  • Shareholders: Positive impact through increased alignment of director's interests with long-term company performance.

Next Steps

  • Continued service of Raymond John W as a Director of IonQ.
  • Vesting of the 3,063 RSUs on the earlier of the 2026 Annual Meeting or June 18, 2026.

Key Dates

DateDescription
09/25/2025Date of RSU award transaction.
09/29/2025Date the Form 4 was signed by the attorney-in-fact.
2026 Annual MeetingEarliest possible vesting date for the RSU award, or the date immediately prior if service ends at such meeting, subject to continued service.
06/18/2026Latest possible vesting date for the RSU award, subject to continued service.

Keywords

IonQ, IONQ, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant, Beneficial Ownership, Form 4, Quantum Computing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.